PTC Therapeutics Inc (PTCT)

Finanzdaten der PTC Therapeutics Inc-Aktie (PTCT)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	56.20% 307.06	196.58	213.81	220.38	167.41
Operating Expenses	4.29% 301.24	314.74	423.35	338.00	367.75
Benefits Costs and Expenses	27.79% 464.11	363.17	451.29	355.37	357.11
Costs And Expenses	27.79% 464.11	363.17	451.29	355.37	357.11
Operating Income/Loss	104.93% 5.82	-118.16	-209.54	-117.61	-200.34
Income/Loss From Continuing Operations Before Tax	5.73% -157.05	-166.59	-237.48	-134.99	-189.69
Income Tax Expense/Benefit, Deferred	199.05K% 3.979	-0.002	-50.90	-0.004	-
Income Tax Expense/Benefit	96.26% -1.259	-33.62	-38.60	3.969	-18.80
Income/Loss From Continuing Operations After Tax	17.16% -155.79	-132.97	-198.88	-138.96	-170.89
Net Income/Loss	17.16% -155.79	-132.97	-198.88	-138.96	-170.89
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.71% 0.2198	75.38	74.73	73.73	0.3128
Diluted Average Shares	99.71% 0.2198	75.38	74.73	73.73	0.3128
Basic Earnings Per Share	17.05% -2.06	-1.76	-2.66	-1.88	-2.36
Diluted Earnings Per Share	17.05% -2.06	-1.76	-2.66	-1.88	-2.36
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-